Saudi Chemical Co. vs Jamjoom Pharmaceuticals Factory Co.
A head-to-head of Saudi Chemical Co. (2230) and Jamjoom Pharmaceuticals Factory Co. (4015) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | 2230 | 4015 |
|---|---|---|
| Market Cap | 7.13B SAR | 11.05B SAR |
| P/E (TTM) | 21.15 | 22.16 |
| Forward P/E | — | — |
| P/S | 1.02 | 7.25 |
| P/B | 2.89 | 5.95 |
| EV/EBITDA | 16.19 | 20.41 |
| Dividend Yield | 1.18% | 253.00% |
| Profit Margin | 4.89% | 31.16% |
| Gross Margin | 12.43% | 62.56% |
| Operating Margin | 6.96% | 31.82% |
| Revenue Growth (YoY) | +5.05% | +5.21% |
| FCF Yield | 9.65% | 2.33% |
| Debt / Equity | 45.34 | 1.20 |
| Current Ratio | 1.40 | 4.94 |
Which is better: Saudi Chemical Co. or Jamjoom Pharmaceuticals Factory Co.?
- ✓Larger by market cap: Jamjoom Pharmaceuticals Factory Co.
- ✓Cheaper valuation (lower P/E): Saudi Chemical Co.
- ✓Higher dividend yield: Jamjoom Pharmaceuticals Factory Co.
- ✓More profitable (net margin): Jamjoom Pharmaceuticals Factory Co.
- ✓Faster revenue growth: Jamjoom Pharmaceuticals Factory Co.
- ✓Higher free-cash-flow yield: Saudi Chemical Co.
Across 12 available metrics, Jamjoom Pharmaceuticals Factory Co. leads 7–5.
There's no single "better" — it depends on your goal: income investors may prefer the higher yield, growth investors the faster grower, and value investors the cheaper one. See each stock's page for deeper detail. This is an automated read, not a recommendation.
Share:
Compare Saudi Chemical Co. with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.